Advertisement

From Episodic to Chronic: A Discussion on Headache Transformation

  • Anna Pace
  • Bridget Mueller
Chapter

Abstract

A chronic daily headache (CDH) disorder is a very different illness than the more common episodic headache. While the episodic headache patient must cope with the uncertainty of when and where the next attack will occur, the CDH patient is frequently faced with relentless pain. This chapter aims to answer several questions:

First, how do we define CDH and what is the burden, to the individual and society, of this disorder?

Three to four percent of the worldwide population suffers from a chronic daily headache disorder encompassing chronic migraine, chronic tension-type headache, hemicrania continua, and new daily persistent headache. Second, what do we know about the mechanism underlying the transformation from episodic headache to CDH? We review evidence suggesting an underlying genetic vulnerability and involvement of glutamate, calcitonin-related peptide, and serotonin pathways. Finally, what risk factors shift an episodic headache to a daily or near-daily headache? The impact of medication overuse, obesity, sleep disturbances, stress, depression, and menstrual-related migraines on headache progression is discussed.

Our hope is that a greater understanding of headache transformation will lead to novel treatment approaches. At the very least, an awareness of modifiable risk factors may empower patients and help prevent an episodic headache from transforming to a chronic daily headache disorder.

Keywords

Chronic daily headache Transformed migraine Chronic tension-type headache Headache transformation 

References

  1. 1.
    Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache. 1994;34(1):1–7.CrossRefGoogle Scholar
  2. 2.
    Srikiatkhachorn A, Govitrapong P, Limthavon C. Up-regulation of 5HT-2 serotonin receptor: a possible mechanism of transformed migraine. Headache. 1994;34:8–11.CrossRefPubMedGoogle Scholar
  3. 3.
    Gallai V, Alberti A, Coppola F, Floridi A, Sarchielli P. Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia. 2003;23:166–74.CrossRefPubMedGoogle Scholar
  4. 4.
    Cernuda-Morollón E, Ramon C, Vega J, Martínez-Camblor P, Pascual J. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology. 2013;81:1191–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Cevoli S, Sancisi E, Grimaldi D, Pierangeli G, Zanigni S, Nicodemo M, Cortelli P, Montagna P. Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache. 2009;49:412–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Arruda MA, Guidetti V, Galli F, Albuquerque RCAP, Bigal ME. Frequency of headaches in children is influenced by headache status in the mother. Headache. 2010;50:973–80.CrossRefPubMedGoogle Scholar
  7. 7.
    Meletiche D, Lofland J, Young W. Quality-of-life differences between patients with episodic and transformed migraine. Headache. 2001;41:573–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Munakata J, Hazard E, Serrano D, Klingman D, Rupnow M, Tierce J, Reed M, Lipton R. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2009;49:498–508.CrossRefPubMedGoogle Scholar
  9. 9.
    Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38(7):497–506.CrossRefPubMedGoogle Scholar
  10. 10.
    Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre—clinical characteristics and treatment outcomes. Cephalalgia. 2004;24(6):483–90.CrossRefPubMedGoogle Scholar
  11. 11.
    Carlsen LN, Munksgaard SB, Jensen RH, Bendtsen L. Complete detoxification is the most effective treatment of medication overuse headache: a randomized controlled open-label trial. Cephalalgia. 2017;333102417737779.Google Scholar
  12. 12.
    Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48(8):1157–68.CrossRefPubMedGoogle Scholar
  13. 13.
    Thorland K, Sun-Edelstein C, Druyts E, Kanters S, Ebrahim S, Bhambri R. Risk of medication overuse headache across classes of treatments for acute migraine. J Headache Pain. 2016;17:107.CrossRefGoogle Scholar
  14. 14.
    Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106:81–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology. 2006;66:545–50.CrossRefPubMedGoogle Scholar
  16. 16.
    Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67:252–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Domínguez C, Vieites-Prado A, Pérez-Mato M, Sobrino T, Rodríguez-Osorio X, López A, Campos F, Martínez F, Castillo J, Leira R. Role of adipocytokines in the pathophysiology of migraine. A cross-sectional study. Cephalalgia. 2017;333102417731351.Google Scholar
  18. 18.
    Novack V, Fuchs L, Lantsberg L, Kama S, Lahoud U, Horev A, Loewenthal N, Ifergane G. Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia. 2011;31(13):1336–42.CrossRefPubMedGoogle Scholar
  19. 19.
    Sancisi E, Cevoli S, Vignatelli L, Nicodemo M, et al. Increased prevalence of sleep disorders in chronic headache: a case-control study. Headache. 2010;50(9):1464–72.CrossRefPubMedGoogle Scholar
  20. 20.
    Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45:904–10.CrossRefGoogle Scholar
  21. 21.
    Calhoun AH, Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache. 2007;47(8):1178–83.CrossRefPubMedGoogle Scholar
  22. 22.
    Johnson KG, Zimeba AM, Garb JL. Improvement in headaches with continuous positive airway pressure for obstructive sleep apnea: a retrospective analysis. Headache. 2013;53(2):333–43.CrossRefPubMedGoogle Scholar
  23. 23.
    Rains JC, Poceta JS. Headache and sleep disorders: review and clinical implications for headache management. Headache. 2006;46(9):1344–63.CrossRefPubMedGoogle Scholar
  24. 24.
    Penzien DB, Rains JC, Holroyd KA. Psychological assessment of the recurrent headache sufferer. In: Tollinson CD, Kunkel RS, editors. Headache: diagnosis and treatment. Baltimore, MD: Williams and Williams; 1993. p. 39–49.Google Scholar
  25. 25.
    D’Amico D, Libro G, Prudenzano MP, Peccarisi C, et al. Stress and chronic headache. J Headache Pain. 2000;1:S49–52.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Paykel ES, Prusoff BA. Scaling of life events. Arch Gen Psychiatry. 1971;25(4):340–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Silberstein S, Olesen J. Chronic migraines. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, editors. The headaches. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. p. 613–7.Google Scholar
  28. 28.
    Costa A, Smeraldi C, Tassorellia R, Grecoa G. Effects of acute and chronic restraint stress on nitroglycerin-induced hyperalgesia in rats. Neurosci Lett. 2005;383:22–9.CrossRefGoogle Scholar
  29. 29.
    Blanchard EB, Appelbaum KA, Radnitz CL, et al. The refractory headache patient—I: chronic, daily, high intensity headache. Behav Res Ther. 1989;27:403–10.CrossRefPubMedGoogle Scholar
  30. 30.
    Holroyd KA, Malinoski PE, O’Donnell FJ, et al. Antidepressant medication and cognitive behavioral therapy for CTTH: predictors of treatment response and dose-response relationships. Headache. 2002;42:456–7.Google Scholar
  31. 31.
    Nash JM, Thebarge RW. Understanding psychological stress, its biological processes, and impact on primary headache. Headache. 2006;46:1377–86.CrossRefPubMedGoogle Scholar
  32. 32.
    Lake AE. Screening and behavioral management: medication overuse headache—the complex case. Headache. 2008;48:26–31.CrossRefPubMedGoogle Scholar
  33. 33.
    Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalgia. 2005;25(3):165–78.CrossRefGoogle Scholar
  34. 34.
    Ashina S, Serrano D, Lipton RB Maizels M, Manack AN, Turkel CC, Reed ML, Buse DC. Depression and risk of transformation of episodic to chronic migraine. Headache Pain. 2012;13:615–24.CrossRefGoogle Scholar
  35. 35.
    Lipton RB, Silberstein SD. Why study the comorbidity of migraine? Neurology. 1994;44:S4–5.CrossRefPubMedGoogle Scholar
  36. 36.
    Rivat C, Becker C, Blugeot A, et al. Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia. Pain. 2010;150:358–68.CrossRefPubMedGoogle Scholar
  37. 37.
    Boudreau GP, Grosberg BM, McAllister PJ, Sheftell FD, Lipton RB, Buse DC. Open-label, multicenter study of the efficacy and outcome of onabotulinumtoxin-A treatment in patients with chronic migraine and comorbid depressive disorders. J Headache Pain. 2010;11:S50.Google Scholar
  38. 38.
    Neugebauer V, Li W, Bird GC, Han JS. The amygdala and persistent pain. Neuroscientist. 2004;10:221–34.CrossRefPubMedGoogle Scholar
  39. 39.
    Zhang M, Liu Y, Zhao M, Wenjing T, Xiaolin W, Zhao D, Shengyuan Y. Depression and anxiety behaviour in a rat model of chronic migraine. Headache Pain. 2017;18(1):27.CrossRefGoogle Scholar
  40. 40.
    Somerville BW. The influence of progesterone and estradiol upon migraine. Headache. 1972;12(3):93–102.CrossRefPubMedGoogle Scholar
  41. 41.
    MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology. 2006;67(12):2154–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of NeurologyIcahn School of Medicine at Mount SinaiNew YorkUSA

Personalised recommendations